MOR Wealth Management’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBRX
MOR Wealth Management's IBRX Position: Q3 2026 in Review
MOR Wealth Management increased its ImmunityBio (IBRX) stake by 4.1% in Q3 2026, buying an estimated $100K and bringing the position to 314,905 shares worth $2.97M. The position accounts for 1.12% of the portfolio, ranked #19.
MOR Wealth Management first reported a position in IBRX in Q4 2025 and has held it in 4 quarters since. 407 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.
- MOR Wealth Management held 314,905 shares of ImmunityBio worth $2.97M as of Q3 2026.
- MOR Wealth Management bought 12,458 ImmunityBio shares in Q3 2026, an estimated $100K.
- ImmunityBio made up 1.12% of MOR Wealth Management's portfolio in Q3 2026, its #19 holding.
- MOR Wealth Management first reported a position in ImmunityBio in Q4 2025 and has held it in 4 quarters since.
- 407 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.
Based on MOR Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.